Journal profile · Biochemistry & Molecular Biology
Hemoglobin
ISSN 0363-0269 · eISSN 1532-432X · Informa Healthcare · UNITED STATES · Quarterly · Founded 1976
Hemoglobin: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.94; subscription journal; APC charged, amount not published; median 113 days to acceptance (102 articles, last 24 months); community-reported acceptance: easy; 75 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hemoglobin is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders and Hemoglobin structure and function, together about 63.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Hemoglobin publishes research and information concerning hemoglobin in humans and other species. Hemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles. The journal covers topics such as: structure, function, genetics and evolution of hemoglobins biochemical and biophysical properties of hemoglobin molecules characterization of hemoglobin disorders (structural variants and thalassemias), consequences and management of hemoglobin disorders epidemiology and prevention of hemoglobin disorders (neo-natal and adult screening) modulating factors methodologies used for the diagnosis of hemoglobin disorders. You will benefit from publishing in Hemoglobin by: Having your work evaluated by the experienced members of our Editorial Board and peer-reviewed by independent experts Featuring in one of the most well-established and highly regarded journals in the field of hemoglobin Receiving 50 free e-prints and tips on promoting your article Increasing the discoverability of your research with Scopus listings and more Tracking downloads, citations, and the Altmetric Score of your article in My Authored Works Gaining recognition from an international audience Increasing your opportunities for future collaborations. Peer Review Policy: All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous peer review.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Adekunle AdekilePublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hemoglobinopathies and Related DisordersMedicine35%
- Iron Metabolism and DisordersMedicine19.2%
- Hemoglobin structure and functionBiochemistry, Genetics and Molecular Biology9.1%
- Blood groups and transfusionMedicine8.6%
- Erythrocyte Function and PathophysiologyMedicine8.2%
- Neonatal Health and BiochemistryMedicine5.2%
- Prenatal Screening and DiagnosticsMedicine2.4%
- Folate and B Vitamins ResearchMedicine1.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCurrent ContentsPublisher website
Other: Index Medicus
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.94LetPub ·
- Impact factor (publisher) 2025
- 1Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.1Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- CiteScore (publisher) 2025
- 1.8Publisher website ·
- SJR 2026-06
- 0.31LetPub ·
- SJR (publisher) 2025
- 0.31Publisher website ·
- SNIP 2026-06
- 0.63LetPub ·
- SNIP (publisher) 2025
- 0.63Publisher website ·
- h-index
- 34LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 1,234OpenAlex ·
- 2-year mean citedness
- 0.77OpenAlex ·
- Self-citation rate
- 10%LetPub ·
- Share of gold OA articles
- 3.28%LetPub ·
Volume
- Articles per year
- 65LetPub ·
- Downloads per year (publisher)
- 54,000Publisher website ·
Articles by year OpenAlex count · 3,522 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 78 | 9 | 9 |
| 2025 | 75 | 11 | 51 |
| 2024 | 69 | 12 | 110 |
| 2023 | 41 | 12 | 155 |
| 2022 | 70 | 8 | 463 |
| 2021 | 76 | 13 | 386 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
113 daysMedian, submission to acceptance · P25–P75 63 days – 190 days
- Acceptance to online
- median 24 days (100 articles)
- Submission to online
- median 144 days
- Sample
- 102 articles with submission and acceptance dates (155 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 33%Publisher website ·
- Submission to first decision
- 28 daysPublisher website ·
- First decision after review
- 45 daysPublisher website ·
- Acceptance to publication
- 28 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- brief reportsHemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles.Length not stated
- data notesHemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles.Length not stated
- letters to the editorHemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles.Length not stated
- method articlesHemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles.Length not stated
- research articlesHemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles.Length not stated
- reviewsHemoglobin publishes research articles, brief reports, reviews, letters to the Editor, data notes and method articles.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Hemoglobin is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership o…
Source ↗Publisher website ·- Peer review
All research articles have undergone rigorous peer review, based on initial editor screening and anonymous peer review. Model summary
Peer Review Policy: All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous peer review.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1976
- ISSN
- 0363-0269
- Electronic ISSN
- 1532-432X
- Latest issue on the website
- Volume 50, Issue 5 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Hemoglobin
What CAS zone is Hemoglobin in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hemoglobin is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hemoglobin?
The latest impact factor listed by LetPub is 0.94; CiteScore 1.8, h-index 60.
How long does peer review take at Hemoglobin?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 113 days (interquartile range 63–190 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 33%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Hemoglobin?
According to LetPub and DOAJ records, Hemoglobin is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is Hemoglobin open access, and what is the APC?
Hemoglobin is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .